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1. Introduction 
The Sivert integral and modular dose calculation models (TG-43) are two methods used for 
calculation of dose distributions around a brachytherapy source (Khan, 2003). Among all 
methods used for calculation of dose distributions, TG-43 has become most popular and 
most promising method because it uses the quantities measured in the medium to calculate 
dose rates. 
In this chapter, we will explain the TG-43 dose calculation formalism and after verification 
of the main reason of its popularity, we will review main defects of this formalism. 
1.1 TG-43 formalism 
In 1995, the American Association of Physicists in Medicine (AAPM)) published a report on 
the dosimetry of sources used in interstitial brachytherapy, Task Group No. 43 (TG-43) 
(Nath et al., 1995). This report introduces dose calculation formalism utilizing new 
quantities like air kerma strength (SK), dose rate constant (Λ), geometry function (G (r,θ)), 
radial dose function (g (r)), and anisotropy function (F (r,θ)). These dosimetry parameters 
consider geometry, encapsulation and self-filtration of the source, the spatial distribution of 
radioactivity within the source, and scattering in water surrounding the source. According 
to this protocol, the absorbed dose rate distribution around a sealed brachytherapy source at 
point P with polar coordinates (r, ߠ) can be determined using the following formalism: ܦ.ሺݎ, ߠሻ ൌ Λ ܵ௞ G ሺr, θሻG ሺr଴, θ଴ሻ ݃ሺݎሻܨ ሺݎ, ߠሻ  (1)
where r is the distance to the point P and ߠ is the angle with respect to the long axis of the 
source, and (r0, ߠ0) is reference point that r0= 1 cm and ߠ0= ߨ/2 (Fig. 1).  
1.1.1 Air kerma strength 
Air kerma strength, Sk, acounts for brachytherapy source strength and is defined as the 
product of air kerma rate at a calibration distance (d) in free space, which is usually chosen 
to be 1 m, along the transverse axis of the source and the square of the distance (d2), 
 Sk=K (d)d2  (2) 
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Fig. 1. The geometry of brachytherapy sources used in TG-43 formalism (Nath et al., 1995). 
Where K (d) is the air kerma rate, and d is the calibration distance (d). The unit of SK is U (1 
U =1 cGy cm2 h-1). 
1.1.2 Dose rate constant 
Dose rate constant, ߉, is defined as dose rate at 1 cm along transverse axis (ߠ0=ߨ/2) of the 
source per unit air kerma strength (U) in a water phantom. Dose rate constant of a 
brachytherapy source is obtained as below: 
 ߉ ൌ ܦሶ 	ሺݎ଴, ߠ଴ሻ/ܵ௞  (3) 
Λ has units of cGy h-1 U-1. As indicated in Task Group No. 43, the effects of source geometry, 
the spatial distribution of radioactivity within the source, encapsulation, and self-filtration 
within the source and scattering in water surrounding the source is considered by this 
parameter. 
1.1.3 Geometry function 
Spatial distribution of radioactivity within the source and the slump of the photon fluence 
with distance from the source are considered by Geometry function, G (r, ߠ), with the unit of 
cm-2. 
For point sources, the geometry function indicates the inverse square law.  
ܩሺݎ, ߠሻ ൌ ቐ ݎିଶ, ܲ݋݅݊ݐ ݏ݋ݑݎܿ݁ߚܮݎ ݏ݅݊ߠ , ܮ݅݊݁ ݏ݋ݑݎܿ݁  (4)
As it is shown in Figure 1, L is the source active length and β =ߠ2-ߠ1 is the angle covering 
active source from the point (r, ߠ). 
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1.1.4 Radial dose function 
Radial dose function, g (r), takes into account slump of dose rate arising from absorption 
and scattering in the medium on the transverse axis of the source and can be affected by self 
filtration, and encapsulation. 
According to AAPM Task Group 43, radial dose function is defined as: ݃ሺݎሻ ൌ ܦ.ሺݎ, ߠ଴ሻܩሺݎ଴, ߠ଴ሻܦ.ሺݎ଴, ߠ଴ሻܩሺݎ, ߠ଴ሻ  (5)
This quantity is defined just on transverse axis, i.e., ߠ0=ߨ/2. As it is obvious from equation 
9.5, effect of the geometric falloff of the photon fluence with distance from the source 
(inverse square law) has been suppressed by G (r0, ߠ0)/G (r, ߠ0). 
1.1.5 Anisotropy function 
Angular variation of photon absorption and scattering in the encapsulation and the medium 
at different distances and angles from the source is taken into account by Anisotropy 
function, F (r, ߠ). ܨሺݎ, ߠሻ ൌ ܦ.ሺݎ, ߠሻܩሺݎ, ߠ଴ሻܦ.ሺݎ, ߠ଴ሻܩሺݎ, ߠሻ  (6)
Where ߠ0=ߨ/2. 
Like g (r), applying geometry function in above equation is suppressing the effect of inverse 
square law on the dose distribution around the source. 
Since the publication of TG-43 formalism, many investigations have been performed on 
determination of the dosimetry parameters of brachytherapy sources and verification of its 
advantages and limitations of this protocol (Liu et al.,2004; Meigooni et al., 2003, 2005; 
Melhus & Rivard, 2006; Parsai et al., 2009; Rivard et al., 2004, 2007; Sina et al., 2007, 2009, 
2011; Song & Wu, 2008; Zehtabian et al., 2010).  
1.1.6 TG-43U1 
An updated version of TG-43 (named TG-43U1) protocol were published on 2004, adding 
several corrections to the original protocol (Rivard et al., 2004).  ܦሶ ሺݎ, ߠሻ ൌ Λ ܵ௞ G୐ ሺr, θሻG୐ ሺr଴, θ଴ሻ ݃௅ሺݎሻܨ ሺݎ, ߠሻ  (7)
Equation (9-10) includes additional notation compared with the corresponding equation in 
the original TG-43 formalism, namely the subscript ‘‘L’’ has been added to denote the line 
source approximation used for the geometry function. 
The definition of Sk in TG-43U1 differs in two important ways from the original AAPM 
definition of Sk. 
The quantity Air-kerma strength, SK , is the air-kerma rate, Kδ (d), in vacuo and due to 
photons of energy greater than δ, at distance d from , multiplied by the square of the 
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distance which should be located on the transverse plane of the source. This distance (d) can 
be any distance large relative to the maximum linear dimension of the radioactivity 
distribution typically of the order of 1 meter.  
 Sk=Kδ (d)d2   (8) 
When Sk is obtained experimentally, the measurements should be corrected for photon 
attenuation and scattering in air and any other medium interposed between the source and 
detector, as well as photon scattering from any nearby objects including walls, floors, and 
ceilings (Rivard et al., 2004). 
The low-energy or contaminant photons (e.g., characteristic x-rays originating in the outer 
layers of steel or titanium source cladding) would increase Kδ (d) without contributing 
significantly to dose at distances greater than 0.1 cm in tissue. Therefore a cutoff energy δ 
(i.e. 5 keV for low-energy photon emitting brachytherapy sources) should be considered in 
calculating Kδ (d).  
In TG-43U1 dose-calculation formalism, a subscript X has been added to the notation g (r) 
and geometry function of the original protocol. This protocol presents tables of both gP (r) 
(point source approximation) and gL (r) (Line source approximation) values. gX (r) is equal to 
unity at r0=1 cm. gଡ଼ሺrሻ ൌ ܦሶ ሺݎ, ߠ଴ሻܩ௑ሺݎ଴, ߠ଴ሻܦሶ ሺݎ଴, ߠ଴ሻܩ௑ሺݎ, ߠ଴ሻ  (9)
The 2D anisotropy function, F (r,θ ), is defined as: Fሺr, θሻ ൌ ܦሶ ሺݎ, ߠሻܩ௅ሺݎ, ߠ଴ሻܦሶ ሺݎ, ߠ଴ሻܩ௅ሺݎ, ߠሻ (10)
The definition of 2D anisotropy function is identical to the original TG-43 definition, other 
than inclusion of a subscript L, which is added to geometry function.  
Generally the TG-43U1 includes: 
a. A revised air-kerma strength (SK) definition. 
b. Not using apparent activity for specification of source strength 
c. Distance-dependent one-dimensional anisotropy function 
d. Guidance on extrapolating tabulated TG-43 parameters to long and short distances 
e. Minor correction of the original protocol and its implementation (Rivard et al., 2004).  
2. Limitations of TG-43 and TG-43U1 dose calculation formalisms 
The dosimetry parameters used in the AAPM TG-43 and TG-43U1 dosimetry formalisms are 
obtained for a single brachytherapy source located at the center of a fixed volume, 
homogeneous liquid water phantom (Nath et al., 1995; Rivard et al., 2004, 2007). Consequently, 
these formalisms does not readily account for several aspects that undermine acquisition of 
high-quality clinical results (Rivard et al., 2009). Some important limitations of TG-43 and TG-
43U1 are listed in the following sections (section 9.3.1 and 9.3.4).  
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2.1 The dosimetry phantom 
As mentioned previously, the TG-43 parameters of a brachytherapy source are obtained in a 
homogeneous water phantom, but in actual clinical cases, the brachytherapy sources are 
located inside the tissues of the patients.  
The different mass absorption coefficients, radiation scattering and attenuations in materials 
with different compositions would alter the dose distribution in comparison with water.  
For example, the brachytherapy sources are placed inside the soft tissue, which is almost 
equivalent to water, with some small differences in density, atomic number Zeff and chemical 
composition. Such differences between the compositions of soft tissue and water may cause 
some discrepancies between the TG-43 parameters in phantoms made up of such materials.  
There are also other tissues inside the human body with more differences in density, atomic 
number and chemical compositions (i.e. bone, breast, lung, …), for which much more 
discrepancies are observed in TG-43 parameters compared with water phantom. Table 1, 
shows the chemical compositions and densities of some tissues according to ICRU 44 (ICRU, 
1989).  
 
Muscle 4 component 
soft tissue 
bone  
 
1.04 1.04 0.92 Density (g/cm3) 
 
Atomic 
number 
Element 
10.1997% 10.1172% 6.3984% 1  (H2) 
12.3% 11.1% 27.8% 6  (C) 
3.5% 2.6% 2.7% 7  (N2) 
72.9003% 76.1828% 41.0016% 8  (O2) 
   9  (F) 
0.08%   11  (Na) 
0.02%  0.2% 12  (Mg) 
   14  (Si) 
0.2%  7% 15  (P) 
0.5%  0.2% 16  (S) 
   17  (Cl) 
0.3%   19  (K) 
  14.7% 20  (Ca) 
Table 1. The chemical compositions and densities of some tissues (ICRU, 1989) 
The effect of phantom material on dose distribution around brachytherapy sources and TG-
43 parameters increases with decreasing the photon energy because of the dependence of 
photoelectric effect on photon energy and the effective atomic number of the absorbing 
materials. 
The ratios of photon mass absorption coefficient of different tissues (μen tissue) to the mass 
absorption coefficient (μen water) of water (ቀఓ೐೙ఘ ቁ௪௔௧௘௥௧௜௦௦௨௘) are shown on Table 2 for some 
energies (20, 30, 100, 300, 600, and 1000 keV).  
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Energy (keV) Bone fat Muscle 
20 4.57 0.56 1.03 
30 4.80 0.58 1.04 
100 1.12 0.96 1.00 
300 0.97 1.00 0.99 
600 0.96 1.00 0.99 
1000 0.96 1.00 0.99 
Table 2. The ratio of mass absorption coefficients of different tissues to water (ቀఓ೐೙ఘ ቁ௪௔௧௘௥௧௜௦௦௨௘) 
(Khan, 2003). 
As it can be seen from Table 2, the difference between mass absorption coefficients in 
phantoms are more pronounced sources of low energy photons.  
To compare the dose distribution in diffeternt dosimetry phantoms, we performed MCNP4c 
(UT-Battelle & LLC, 2000) Monte Carlo calculations of The Selectron low dose rate (LDR) Cs-
137 pellet sources of Nucletron (Nucletron BV, Netherland) (Nucletron, 1998) in 
homogeneous cubical water phantom of dimention 30*30*30 cm to obtain the dose distribution 
around a combination of 10 active pellets inside the cylindrical applicator, and then we 
repeated the MC simulations for different phantom materials (i.e. bone, muscle and soft 
tissue). The small cubical lattice of 1 mm dimension was defined in the phantoms in order to 
score dose distribution around the sources inside homogeneouse phantoms using tally F6.  
Figure 2, compares the dose distribution around ten active pellets in a cubical water phantom 
with the dose distribution in bone phantom. The active spherical sources and inactive pellets 
along with the components of the cylindrical applicator can be seen on the figure. 
According to the results of MC simulations, the percentage difference between the dose in 
water and bone phantoms at transverse plane of the source, increase by increasing the 
distance from the source center. For instance the percentage difference between the dose in 
bone and water at a point located at r=0.5 cm on transverse axis of the source is 3%, but this 
value increases to 20% at r=10 cm.  
The comparison between the dose distribution around Cs-137 pellets in water phantom and 
other phantoms (soft tissue, and muscle) shows the percentage difference of about 3% at 
r=10 cm which are less pronounced than the percentage difference between bone and water, 
this is because of the difference in density and effective atomic numbers of these tissues (see 
Table 1) which lead to different mass attenuation and absorption coefficient of photons. 
Melhus et al 2006 investigated the ratio of g (r) in different phantoms (i.e. ICRU 44, four-
component soft tissue, breast, Muscle, and soft tissue) to g (r) in water phantom for different 
brachytherapy sources (i.e. I-125, Cs-137, Ir-192, Pd-103, and Yb-169) using MCNP5 Monte 
Carlo code (Melhus & Rivard, 2006). 
The ratios of g (r) tissue to g (r) water are shown for different brachytherapy sources are shown 
in Figure 3 (Melhus & Rivard, 2006). 
According to Figure 3, the difference between g (r) tissue and g (r) water increase with 
decreasing photon energy. 
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Fig. 2. Comparison of the dose distribution around a combination of 10 Cs-137 active pellets 
in homogeneous water phantom and bone phantom. 
Melhus et al 2006, reported a factor of 2 differences in g (r) between water and ICRU 44 
breast tissue for 103Pd at a depth of 9 cm, and the difference of approximately 30% between g 
(r) for ICRU muscle and soft tissue at a depth of 9 cm for both 125I and 103Pd.  
2.2 Inhomogenities 
According to the TG-43 dose calculation formalism, the dosimetry is performed in a uniform 
medium (water) phantom and inhomogenities like bony and soft tissues were not taken into 
account. There are some implant sites such as head and neck and lung in which the existing 
inhomogenities are important and would change the dosimetry parameters of the 
brachytherapy source. 
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Fig. 3. The ratio of g (r) in different tissues to g (r) in water, for different brachytherapy 
sources, (i.e. I-125, Cs-137, Ir-192, Pd-103, and Yb-169) (with permission of Med Phys 
Journal) (Melhus & Rivard, 2006). 
In 2008, Song et al performed a study on AAPM TG-43 dose calculation formalism in 
heterogeneous media for three radioactive seeds (125I, 192Ir and 103Pd). They recommended 
the modified dose rate constants in different heterogeneities (઩' (bone)=5.030 and 4.06 
cGy/hU for I-125 and Pd-103 respectively) (Song & Wu, 2008).  
In 2010 we performed investigation on the effects of tissue inhomogeneities on the 
dosimetric parameters of a Cs-137 brachytherapy source using the MCNP4C code 
(Zehtabian et al., 2010). We defined an updated dose rate constant parameter, for Cs-137 
source in presence of tissue inhomogenities. The MCNP4C simulations were performed in 
phantoms composed of water, water-bone and water-air combinations (see Figure 4). The 
values of dose at different distances from the source in both homogeneous and 
inhomogeneous phantoms were estimated in spherical tally cells of 0.5 mm radius using the 
F6 tally. The percentages of dose reductions in presence of air and bone inhomogenities for 
the Cs-137 source were found to be 4% and 10%, respectively. Therefore, the updated dose 
rate constant (Λ) will also decrease by the same percentages. The dose rate constant of a 
single active pellet inside the liquid water phantom was 1.093. The modified values of dose 
rate constant (઩'a) for air and bone inhomogenitis were found to be 0.984 and 1.047 
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respectively (Zehtabian et al., 2010). By comparing our results and Song et al results, it can 
be easily concluded that such dose variations are more noticeable when using lower energy 
sources such as Pd-103 or I-125 because of prevail of photoelectric effect.  
    
Fig. 4. Simulated geometry of a single active Cs-137 pellet inside the phantom a) uniform 
water phantom b) Water phantom with inhomogenity (bone or air) (with permission from 
Iranian Journal of Medical Physics) (Zehtabian et al., 2010). 
2.3 InterSource Attenuation (ISA) and influence of applicators 
For clinical applications, in which several brachytherapy sources are used in treatment of 
the patients, the ISA may be significant. 
TG-43 parameters of brachytherapy sources are obtained for single brachytherapy sources 
inside a homogenious water phantom, not considering the effect of other brachytherapy 
sources (ISA) and the applicators (Markman et al., 2001).  
The structures of brachytherapy sources and the applicators are composed of materials with 
the densities and atomic numbers different from that of water. The photoelectric effect is 
more dominant in materials with higher atomic numbers, so the TG-43 parameters are 
different when shielding effects of the applicator and other source are considered in 
comparison to the water without consideration of these factors (Rivard et al., 2009). 
The radio-opaque markers (i.e. silver markers Z=47) which are used in identification during 
post Implant CT localization in LDR brachytherapy may also cause some inaccuracies in 
TG-43 dose calculation formalism. 
The applicators which are made up of materials with the atomic numbers different from that 
of water (i.e. stainless steel=26) would also cause some errors in TG-43 parameters.  
The difference between the TG-43 parameters of brachytherapy sources in applicator 
materials are highly dependent on the energy of brachytherapy sources. Consequently not 
considering the ISA and the applicator effects are more pronounced for brachytherapy 
sources emitting low energy gamma rays. 
Different investigators have studied the shielding effects of other materials (such as the 
other sources, the applicator components and radio opaque markers) and showed that not 
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taking the radiation attenuation in such materials into consideration may have significant 
effect on dose distribution around the brachytherapy sources (Margarida Fragoso, 2004; M. 
Fragoso et al., 2004; Parsai et al., 2009; Perez-Calatayud et al.,2004, 2005; Sina et al., 2007, 
2011; Siwek et al., 1991).  
To investigate the shielding effect of the cylindrical vaginal applicator and dummy pellets 
on TG-43 dosimetry parameters of Cs-137 low dose rate brachytherapy source, we simulated 
a single active pellet inside the applicator and calculated the geometry parameters of the 
source (i.e. dose rate constant, radial dose function and anisotropy function) ( Sina et al., 
2009, 2011a, 2011b). 
According to the results of our study, the presence of the applicator does not have any 
significant effect on the dose rate constant and radial dose function of the source (θ=90°), but 
the value of anisotropy function differs from unity especially towards the longitudinal axis 
of the source (θ=0° or θ=180°). Figure 5 shows the anisotropy function of an active pellet 
inside the applicator (while other pellets are inactive) at different distances from the center 
of the source. As it is obvious from Figure 5, the value of F (r,θ) are equal to unity at θ=90°, 
and decrease as the angles reaches 0° and 180°. 
 
Fig. 5. Comparison of the anisotropy function at different distances and angles from the 
source (with permission of IJRR). (Sina et al., 2009) 
2.4 Phantom size 
Differences between radiation scattering for dataset acquisition and patient treatment would 
also cause some errors in dose calculations based on TG-43 formalism. In actual clinical 
cases the brachytherapy sources is not placed exactly at the center of the patient’s body. 
Sometimes the radioactive source is placed near the patient’s contour, and this change in the 
scattering condition inside the phantom, would have significant effects on TG-43 parameters 
of the sources.  
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The percentages of difference in TG-43 parameters are highly affected by energy of the photons 
emitted from brachytherapy sources, and the amount of missing tissue (the phantom size).  
Several investigators has studied the phantom size as an important point in BT dosimetry 
study is the phantom size involved either in MC calculations or experimental measurements 
(Anagnostopoulos et al., 1991, 2003; Herbold et al., 1988; Karaiskos et al., 2003; Sakelliou et 
al., 1992; Tiourina, 1995). Williamson 1991, showed 5%–10% differences at distances greater 
than 5cm from a 192Ir source comparing the dose in an unbounded liquid–water and a 
phantom of of nearly 20*20*20 cm3 (Williamson, 1991). Venselaar et al. have investigated the 
influence of phantom size on dose by changing the water level in a cubic water tank for 
137Cs, 60Co and 192Ir sources (Venselaar et al., 1996). They obtained significant differences in 
the dose between experiments with different phantom sizes. Karaiskos et al. investigated the 
effect of water spherical phantom size on 192Ir MicroSelectron HDR source of diameters 
ranging from 10 to 50 cm on the radial dose function, g (r), at radial distances near phantom 
boundaries, both experimentally and theoretically, and observed up to 25% differences at 
the points near the phantom boundaries (Karaiskos et al., 2003). It is better to take such 
differences into account in the dose calculations of the treatment planning softwares in 
clinical cases which the sources are located near the phantom boundaries. 
Pe´rez-Calatayud et al verified the influence of phantom size on the radial dose function of 
different brachytherapy sources using GEANT4 code. They found that a 15 cm radius water 
phantom ensures full scatter conditions up to 10 cm from the low energy photon emitting 
brachytherapy sources like 103Pd, and 125I (Perez-Calatayud, 2004). They also suggested the 
unbounded phantom radius of 40cm for 137Cs and 192Ir sources. 
 
Fig. 6. Ratio between the radial dose function for a phantom size R and the radial dose 
function for an unbounded phantom, for 137Cs, 192Ir, 125I and 103Pd point sources and for 
various phantom sizes (Perez-Calatayud, 2004). 
Melhus et al 2006, also compared the g (r) values for different phantom sizes with the values 
of g (r) for a phantom size of R=50cm using MCNP5 Monte Carlo code and found that the 
MCNP5 results were in agreement with the GEANT4 code (see Figure 7). 
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Fig. 7. Comparison of g (r) values for phantoms of different sizes with the phantom of 
R=50cm, for different brachytherapy sources. (Melhus & Rivard, 2006) 
3. Conclusions  
Today, most of brachyherapy treatment planning systems are based on the recommendations 
of AAPM Task Group #43 dose calculation formalism (TG-43). The tabulated data including 
TG-43 parameters of the brachytherapy sources which are obtained experimentally or 
theoretically, are used as the input data of the treatment planning softwares. The TG-43 
parameters are obtained by positioning the source at the center of a fixed volume 
homogeneous water phantom, not considering the different scattering and attenuation of the 
photons in other tissues, the phantom size and the ISA and the applicator shielding effects.  
Such limitations would affect the outcome of the treatment planning softwares. It is 
recommended that such factors be taken into considerations as much as possible, by 
applying some correction factors.  
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